Former EY partner Hee H. Lee joins Alps Group (ALPS) board

Rhea-AI Filing Summary

Alps Group Inc has appointed Mr. Hee H. Lee to its Board of Directors, effective April 17, 2026, expanding the Board from five to six members. He is considered independent under Nasdaq rules and is expected to join both the Audit Committee and the Compensation Committee.

Mr. Lee is a New York-licensed Certified Public Accountant with more than three decades of public accounting and advisory experience, including as a Partner at Ernst & Young LLP and long-standing advisory work with the International Swaps and Derivatives Association. The company operates an integrated biotechnology and healthcare platform focused on predictive, preventive, and precision medicine.

Key Figures

Board size after appointment: 6 directors Board size before appointment: 5 directors Appointment effective date: April 17, 2026 +2 more

5 metrics

Board size after appointment 6 directors Board of Directors size following Mr. Lee’s appointment

Board size before appointment 5 directors Board of Directors size prior to Mr. Lee’s appointment

Appointment effective date April 17, 2026 Effective date of Mr. Lee’s appointment to the Board

Professional experience Over 35 years Mr. Lee’s experience in public accounting and advisory services

ISDA advisory tenure More than 20 years Mr. Lee’s service as advisor to the International Swaps and Derivatives Association

Key Terms

independent, Audit Committee, Compensation Committee, capital markets, +2 more

6 terms

independent financial

"Mr. Lee is considered independent under applicable Nasdaq rules"

Audit Committee financial

"Mr. Lee is expected to serve as a member of the Audit Committee"

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

Compensation Committee financial

"expected to serve as a member of the Audit Committee and the Compensation Committee"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

capital markets financial

"capital markets matters. At EY, Mr. Lee established and led"

Capital markets are places where people and organizations buy and sell long-term investments like stocks and bonds. They help connect those who need money to grow or fund projects with investors looking to earn returns over time. For investors, capital markets are important because they offer opportunities to invest, save, and grow their wealth through a variety of financial assets.

forward-looking statements regulatory

"Certain statements in this press release may be considered to contain certain “forward-looking statements”"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Private Securities Litigation Reform Act of 1995 regulatory

"within the meaning of “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995"

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number: 001-42915

Alps Group Inc

(Registrant’s Name)

Unit E-18-01 & E-18-02, Level 18, Icon Tower (East)

No. 1, Jalan 1/68F, Jalan Tun Razak

50400 Kuala Lumpur

Wilayah Persekutuan, Malaysia

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Appointment of Board Member

The board of directors (“Board”) of Alps Group Inc ( “Company”) announces that Mr. Hee H. Lee (“Mr. Lee”) has been appointed as a director of the Company, effective April 17, 2026. In connection with the appointment, the number of members of the Board will increase from five (5) to six (6). Mr. Lee is independent pursuant to applicable Nasdaq rules.

Mr. Lee has over 30 years of experience in the financial services sector. He served as a Partner at Ernst & Young LLP from July 2013 to June 30, 2025, during which period he established and led the Americas Financial Accounting Advisory Services practice. In addition, he served as an advisor to the International Swaps and Derivatives Association for more than 20 years.

Mr. Lee holds a Master of Accountancy and Financial Information Systems from Cleveland State University and a Bachelor of Business Administration from the University of Louisiana at Lafayette. He is a Certified Public Accountant licensed in the State of New York.

The Board believes Mr. Lee will bring abroad extensive and relevant professional experience to the Company. Mr. Lee is expected to serve as a member of both the Audit Committee and the Compensation Committee of the Board.

The Company issued a press release on April 17, 2026 announcing the appointment of the director, and is furnished as Exhibit 99.1.

Exhibits

Exhibit No.		Description
99.1*		Press Release dated April 17, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Alps Group Inc
Date: April 17, 2026	By:	/s/ Dr. Tham Seng Kong
	Name:	Dr. Tham Seng Kong
	Title:	Chief Executive Officer and Director

Exhibit 99.1

Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight

KUALA LUMPUR, Malaysia, April 17, 2026 - Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a biotechnology research and healthcare platform focused on predictive, preventive, and precision medicine, announced the appointment of Mr. Hee H. Lee (“Mr. Lee”) to its Board of Directors (the “Board”), effective April 17, 2026. The Company’s Board will increase from five (5) to six (6) directors in connection with this appointment. Mr. Lee is considered independent under applicable Nasdaq rules and is expected to serve as a member of the Audit Committee and the Compensation Committee.

Mr. Lee has over 35 years of experience in the public accounting and advisory services, including his tenure as a Partner at Ernst & Young LLP (“EY”) within its Global Financial Services Organization. During his career, Mr. Lee advised boards of directors and senior management of financial institutions on financial reporting, corporate governance, structured transactions, and capital markets matters.

At EY, Mr. Lee established and led the Americas Financial Accounting Advisory Services (“FAAS”) practice within the financial services sector. His experience spans asset management, banking, insurance, private equity, and fintech/digital assets. He has advised on derivatives, securitization, structured financing, initial public offerings, and mergers and acquisitions, and served for more than 20 years as an advisor to the International Swaps and Derivatives Association (“ISDA”), contributing to the development and interpretation of industry standards affecting global capital markets.

Mr. Lee is a Certified Public Accountant licensed in the State of New York and a member of the American Institute of Certified Public Accountants. He holds a Master of Accountancy and Financial Information Systems from Cleveland State University and a Bachelor of Business Administration from the University of Louisiana at Lafayette. He has also completed executive education programs in board and leadership development at Harvard University and the Kellogg School of Management.

“Mr. Lee’s experience in financial reporting, governance, and capital markets will strengthen the Board’s oversight and support the Company’s ongoing development as a public company,” said Dr. Tham Seng Kong, Chief Executive Officer of Alps Group.

“I am pleased to join the Board of Alps Group Inc and look forward to contributing to the Company’s strategic direction and governance framework. The Company’s focus on healthcare innovation is aligned with my professional and personal interests, and I look forward to working with the Board and management team.” said Mr. Lee.

About Alps Group

Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. Alps Group’s mission is to create a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable.

Forward-Looking Statements

Certain statements in this press release may be considered to contain certain “forward-looking statements” within the meaning of “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “target,” “believe,” “expect,” “will,” “shall,” “may,” “anticipate,” “estimate,” “would,” “positioned,” “future,” “forecast,” “intend,” “plan,” “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company management’s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

A further list and description of risks and uncertainties can be found in documents filed with the Securities and Exchange Commission (“SEC”) by the Company and other documents that we may file or furnish with the SEC, which you are encouraged to read. Any forward-looking statement made by us in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise, except as required by law.

Investor Relations Contact

Alps Group Inc

Email: investorrelations@alpsmedical.com

FAQ

What did Alps Group Inc (ALPS) announce in this 6-K filing?

Alps Group Inc announced the appointment of Mr. Hee H. Lee to its Board of Directors, effective April 17, 2026. His appointment increases the Board size and adds deep financial reporting and capital markets expertise to board-level oversight.

How does Mr. Hee H. Lee’s appointment change the Alps Group (ALPS) Board structure?

Mr. Lee’s appointment increases the Board from five to six directors, adding an additional independent member. He is expected to serve on the Audit Committee and the Compensation Committee, expanding financial and governance oversight capabilities at the committee level.

What is Mr. Hee H. Lee’s professional background relevant to Alps Group (ALPS)?

Mr. Lee has over 35 years of public accounting and advisory experience, including as a Partner at Ernst & Young LLP. He has advised financial institutions on reporting, governance, structured transactions, and capital markets, and served more than 20 years as an advisor to ISDA.

Why is Mr. Hee H. Lee considered an independent director at Alps Group (ALPS)?

The company states that Mr. Lee is considered independent under applicable Nasdaq rules. Independence generally means he does not have relationships that could impair objective judgment, supporting stronger board oversight of financial reporting, compensation, and broader governance matters.

Which board committees will Mr. Hee H. Lee join at Alps Group (ALPS)?

Mr. Lee is expected to serve on the Audit Committee and the Compensation Committee of the Board. These committees oversee financial reporting, internal controls, and executive pay, areas well aligned with his background in accounting, governance, and capital markets.

What sector does Alps Group Inc (ALPS) operate in?

Alps Group Inc is the parent of Alps Life Sciences Inc, an integrated biotechnology and healthcare platform. The business focuses on predictive, preventive, and precision medicine, combining research and development, medical services, and wellness solutions within one ecosystem.

Filing Exhibits & Attachments

2 documents

Press Releases

• EX-99.1 EX-99.1 13.7 KB
• EX-99 GRAPHIC 5.2 KB